'''Triflubazam'''<ref>US Patent 3660381 -5-ARYL-1H-1 5-BENZODIAZEPINE-2 4-DIONES</ref> is a drug which is a 1,5-[[benzodiazepine]] derivative, related to [[clobazam]].<ref>{{cite web |url=http://www.psychotropics.dk/moleculeView/default.aspx?ID=1451&Catalogtype=A&ChapterID=1&Thissortorder=48 |title=triflubazam |author=Lundbeck Institute |authorlink=lundbeck |year=2003 |publisher=psychotropics.dk |accessdate=17 November 2010 }}</ref> It has [[sedative]] and [[anxiolytic]] effects, with a long half-life and duration of action.<ref>Itil TM, Akpinar S, Fink M: Controlled clinical and quantitative EEG studies of triflubazam (ORF 8063) in patients with anxiety syndrome. ''Current Therapeutic Research'' 1976; 19: 307-315</ref><ref>Csanalosi I, Pereira-Oran J, Case G, et al.: Triflubazam (ORF 8063), a new benzodiazepine in anxiety neurosis. ''Current Therapeutic Research'' 1977; 22: 166-171</ref><ref>Nicholson AN, Stone BM, Clarke CH. Effect of the 1,5-benzodiazepines, clobazam and triflubazam, on sleep in man. ''British Journal of Clinical Pharmacology''. 1977 Oct;4(5):567-72.</ref>
